Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Nature Communications|October 8, 2025
Cryo-EM structure of the yeast Saccharomyces cerevisiae SDH provides a template for eco-friendly fungicide discoveryZhi-Wen Li, Yuan-Hui Huang, Ge Wei, et al.
Cellular & Molecular Immunology|December 8, 2021
The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signalingBo Wu, Lihua Qiang, Yong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or MutationsGang G Li, Romel Somwar, James Joseph, et al.
Cell|July 23, 2022
Large-scale multiplexed mosaic CRISPR perturbation in the whole organismBo Liu, Zhengyu Jing, Xiaoming Zhang, et al.
Nature Structural & Molecular Biology|February 24, 2009
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesJianhua Sui, William C Hwang, Sandra Perez, et al.
Cancer Discovery|November 8, 2015
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal CancerMariangela Russo, Sandra Misale, Ge Wei, et al.
Annals of Clinical and Translational Neurology|March 10, 2017
PH20 is not expressed in murine CNS and oligodendrocyte precursor cellsMathieu Marella, Joe Ouyang, Jonathan Zombeck, et al.
The Journal of Biological Chemistry|June 1, 2007
Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogensSergey A Shiryaev, Albert G Remacle, Boris I Ratnikov, et al.
Molecular Cancer Therapeutics|March 5, 2016
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer IndicationsElena Ardini, Maria Menichincheri, Patrizia Banfi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II StudyAndrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, et al.
Pageof 10